These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 38847110)
1. PD-L1 and PD-L2 Expression in Different Tumor Stages and Types of Malignant Salivary Gland Neoplasms: A Single-center Experience. Yaprak Bayrak B; Cam I; Civriz AH; Tunce EB; Ozcan BC; Akyol YK; Deger HM; Vural C; Ozturk M Appl Immunohistochem Mol Morphol; 2024 Jul; 32(6):264-271. PubMed ID: 38847110 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of programed death ligand-1 and ligand-2 co-expression in salivary gland carcinomas. Nakano T; Takizawa K; Uezato A; Taguchi K; Toh S; Masuda M Oral Oncol; 2019 Mar; 90():30-37. PubMed ID: 30846173 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous Expression of PD-1 and PD-L1 in Peripheral and Central Immune Cells and Tumor Cells in the Benign and Malignant Salivary Gland Tumors Microenvironment. Gerdabi S; Asadian F; Kiani R; Khademi B; Haghshenas MR; Erfani N Head Neck Pathol; 2023 Mar; 17(1):178-192. PubMed ID: 36169795 [TBL] [Abstract][Full Text] [Related]
4. Immune microenvironment and evasion mechanisms in adenoid cystic carcinomas of salivary glands. Mosconi C; de Arruda JAA; de Farias ACR; Oliveira GAQ; de Paula HM; Fonseca FP; Mesquita RA; Silva TA; Mendonça EF; Batista AC Oral Oncol; 2019 Jan; 88():95-101. PubMed ID: 30616805 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of expressions of STAT3, PD-L1, and PD-L2 in Ta/T1 urothelial carcinoma before and after BCG treatment. Civriz AH; Teke K; Akdas EM; Dillioglugil O; Vural C; Yaprak Bayrak B Urol Oncol; 2023 Dec; 41(12):486.e1-486.e13. PubMed ID: 37690934 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland. Sasahira T; Kurihara M; Yamamoto K; Bhawal UK; Kirita T; Kuniyasu H Cancer Sci; 2011 Feb; 102(2):492-7. PubMed ID: 21105967 [TBL] [Abstract][Full Text] [Related]
7. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Schwarz S; Müller M; Ettl T; Stockmann P; Zenk J; Agaimy A Int J Clin Exp Pathol; 2011 Apr; 4(4):336-48. PubMed ID: 21577319 [TBL] [Abstract][Full Text] [Related]
9. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands. Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177 [TBL] [Abstract][Full Text] [Related]
10. The expression of programed death ligand-1 could be related with unfavorable prognosis in salivary duct carcinoma. Sato F; Akiba J; Kawahara A; Naito Y; Ono T; Takase Y; Murata K; Abe H; Yamaguchi T; Miyoshi H; Abe Y; Mihara Y; Tanikawa M; Akashi M; Kurose H; Umeno H; Yano H J Oral Pathol Med; 2018 Aug; 47(7):683-690. PubMed ID: 29719073 [TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of CD8-positive tumour-infiltrating lymphocytes and PD-L1 expression in salivary gland cancer. Kesar N; Winkelmann R; Oppermann J; Ghanaati S; Martin D; Neumayer T; Balster S; Rödel C; Rödel F; von der Grün J; Balermpas P Oral Oncol; 2020 Dec; 111():104931. PubMed ID: 32736208 [TBL] [Abstract][Full Text] [Related]
12. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors. Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671 [TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 overexpression in benign and malignant salivary gland tumors. Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261 [TBL] [Abstract][Full Text] [Related]
14. Programmed death ligand 1 and CD8+ immune cell infiltrates in resected primary tracheal malignant neoplasms. Tapias LF; Shih A; Mino-Kenudson M; Muniappan A; Gaissert HA; Lanuti M; Mathisen DJ; Ott HC Eur J Cardiothorac Surg; 2019 Apr; 55(4):691-698. PubMed ID: 30418532 [TBL] [Abstract][Full Text] [Related]
15. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance. Siqueira JM; Mitani Y; Hoff CO; Bonini F; Guimaraes de Sousa L; Marques-Piubelli ML; Purushothaman A; Mitani M; Dai H; Lin SY; Spiotto MT; Hanna EY; McGrail DJ; El-Naggar AK; Ferrarotto R Mod Pathol; 2024 Jan; 37(1):100371. PubMed ID: 38015043 [TBL] [Abstract][Full Text] [Related]
16. NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics. Wong KS; Mariño-Enriquez A; Hornick JL; Jo VY Head Neck Pathol; 2021 Jun; 15(2):425-432. PubMed ID: 32910350 [TBL] [Abstract][Full Text] [Related]
17. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands. Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571 [TBL] [Abstract][Full Text] [Related]
18. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland. Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354 [TBL] [Abstract][Full Text] [Related]
19. Salivary gland epithelial neoplasms in pediatric population: a single-institute experience with a focus on the histologic spectrum and clinical outcome. Xu B; Aneja A; Ghossein R; Katabi N Hum Pathol; 2017 Sep; 67():37-44. PubMed ID: 28739497 [TBL] [Abstract][Full Text] [Related]
20. Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors. Tadbir AA; Pardis S; Ashkavandi ZJ; Najvani AD; Ashraf MJ; Taheri A; Zadeh MA; Sardari Y Asian Pac J Cancer Prev; 2012; 13(10):5155-9. PubMed ID: 23244127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]